DARPA seeks psychedelic drugs that don't cause hallucinations

The government research agency DARPA has announced a new program called Focused Pharma that seeks drug innovations that offer the mental health benefits of psychedelics without the ‘significant side effects.’ The agency detailed its new program earlier this week, revealing that it has reviewed the growing body of private research on the potential benefits of psychedelics like LSD and psilocybin. …